VAN DER HORST EDWARD (Chief Scientific Officer) received a stock award from SENSEI BIOTHERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/17/2023ACC: 0001209191-23-010736
Officer· Chief Scientific Officer
Since Dec 2022
+116.27K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
116.27K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+23.57K
Price / share
—
Trade value
—
% of position
111.3%
2/15/2023
21.17K→44.74K
Common Stock
Direct
Shares
+17.70K
Price / share
—
Trade value
—
% of position
39.6%
2/15/2023
44.74K→62.44K
Total
Net shares
+41.27K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2023 | A · Award | +23.57K | — | — | 111.3% | 21.17K | 44.74K |
| Common Stock Direct | 2/15/2023 | A · Award | +17.70K | — | — | 39.6% | 44.74K | 62.44K |
| Total | +41.27K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
75K shares
Shares
+75K
Strike price
1.43
Held after
75K
Exercisable
—
2/15/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock75K shares | 2/15/2023 | A · Award | +75K | 1.43 | — | 75K |